# Ipca Laboratories to acquire 26.574% stake in Lyka Labs

Ipca Laboratories' board approved the acquisition of a 26.574% stake in Lyka Labs for Rs 97.89 crore, along with a joint management control agreement with Lyka Labs' promoters.

- Type: Acquisition
- Announced: 2021-11-24
- Where: India
- Value: $13.1M (978.9M INR)
- Status: announced
- Products: injectables, lyophilized injectables, topical formulations
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ipca Laboratories](https://endata.com/companies/59222.md) (acquirer)
- [Lyka Labs](https://endata.com/companies/59223.md) (target)

## Sources

- [business-standard.com](https://www.business-standard.com/article/companies/ipca-labs-board-approves-acquisition-of-over-26-stake-in-lyka-labs-121112400677_1.html), 2021-11-24: "Ipca Laboratories on Wednesday said that its board of directors has approved the acquisition of 26.574% of the paid-up share capital of Lyka Labs for a cash consideration of Rs 97.89 crore."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.